The effects of metformin and diet on plasma testosterone and leptin levels in obese men

Obesity Research

Volumn 9, Issue 11, 2001, Pages 662-667

  Ozata, Metin ^a   Oktenli, Cagatay ^a   Bingol, Necati ^b   Ozdemir, I Caglayan ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Bayindir Medical Center   (Turkey)

Author keywords

Diabetes; Leptin; Male; Metformin; Testosterone

Indexed keywords

ANTIDIABETIC AGENT; FOLLITROPIN; LEPTIN; LUTEINIZING HORMONE; METFORMIN; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ARTICLE; BLOOD; BODY CONSTITUTION; BODY MASS; CALORIC INTAKE; DIABETES MELLITUS; FEMALE; HUMAN; LOW CALORY DIET; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY;

ADULT; BODY CONSTITUTION; BODY MASS INDEX; DEHYDROEPIANDROSTERONE SULFATE; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; DIET, REDUCING; ENERGY INTAKE; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; HYPOGLYCEMIC AGENTS; LEPTIN; LUTEINIZING HORMONE; MALE; METFORMIN; MIDDLE AGED; OBESITY; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 0035515324     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2001.90     Document Type: Article

References (41)

1. Stumvoll M, Nurjhan N, Perriello G, Dailey G, Gerich JE. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med. 1995;333:550-4.
2. Cusi K, Consoli A, DeFronzo RA. Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1996; 81:4059-67.
3. Perriello G, Misericordia P, Volgi E, et al. Acute antihyperglycemic mechanisms of metformin in NIDDM: evidence for suppression of lipid oxidation and hepatic glucose production. Diabetes. 1994;43:920-8.
4. Abbasi F, Kamath V, Rizvi AA, Carantoni M, Chen YD, Reaven GM. Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients: evidence for a central role of adipose tissue. Diabetes Care. 1997;20:1863-9.
5. Abbasi F, Carantoni M, Chen YD, Reaven GM. Further evidence for a central role of adipose tissue in the antihyperglycemic effect of metformin. Diabetes Care. 1998;21:1301-5.
6. Mueller WM, Stankope KL, Gregoire F, Evans JL, Havel PJ. Effects of metformin and vanadium on leptin secretion from cultured rat adipocytes. Obes Res. 2000;8:530-9.
7. Mick GJ, Wang X, Ling Fu C, McCormick KL. Inhibition of leptin secretion by insulin and metformin in cultured rat adipose tissue. Biochim Biophys Acta. 2000;1502:426-32.
8. Paolisso G, Amato L, Eccellente A, et al. Effect of metformin on food intake in obese subjects. Eur J Clin Invest. 1998;28:441-6.
9. Campbell IW, Menzies DG, Chalmers J, et al. One-year comparative trial of metformin and glipizide in type 2 diabetes mellitus. Diabetes Metab Rev. 1994;20:394-400.
10. Fontbonne A, Charles MA, Juhan-Vague I, et al. The effect of metformin on the metabolic abnormalities associated with upper-body fat distribution. The BIGPRO Study Group. Diabetes Care. 1996;19:920-6.
11. Lee A, Morley JE. Metformin decreases food-consumption and induces weight-loss in subjects with obesity with type-II non-insulin-dependent diabetes. Obes Res. 1998;6:47-53.
12. U.K. Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in over-weight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854-65.
13. Matthaei S, Stumvoll M, Kellerer M, Haring H-U. Pathophysiology and pharmacological treatment of insulin resistance. Endocrinol Rev. 2000;21:585-618.
14. Makimattila S, Nikkila K, Yki-Jarvinen H. Causes of weight gain during insulin therapy with and without metformin in patients with type II diabetes. Diabetologia. 1999; 42:406-12.
15. Perriello G, Misericordia P, Volpi E, et al. Acute antihyperglycemic mechanisms of metformin in NIDDM: evidence for suppression of lipid oxidation and hepatic glucose production. Diabetes. 1994;43:920-8.
16. Leslie P, Jung RT, Isles TE, Baty J. Energy expenditure in non-insulin dependent diabetic subjects on metformin or sulfonylurea therapy. Clin Sci. 1987;73:41-5.
17. Pasquali R, Gambineri A, Biscotti D, et al. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J Clin Endocrinol Metab. 2000; 85:2767-74.
18. Diamanti Kandarakis E, Kouli C, Tsianateli T, Bergiele A. Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome. Eur J Endocrinol. 1998;138:269-74.
19. World Health Organization. Diabetes Mellitus: Report of a WHO Study Group. Geneva, Switzerland: World Health Organization; 1985. Technical Report Series 727.
20. Lima N, Cavaliere H, Knobel M, Halperin A, Medeiros-Neto G. Decreased androgen levels in massively obese men may be associated with impaired function of the gonadostat. Int J Obes Relat Metab Disord. 2000;24:1433-7.
21. Stanik S, Dornfeld LP, Maxwell MH, Viosca SP, Korenman SG. The effect of weight loss on reproductive hormones in obese men. J Clin Endocrinol Metab. 1981;53:828-32.
22. Barrett-Connor E, Khaw KT, Yen SS. Endogenous sex hormone levels in older adult men with diabetes mellitus. Am J Epidemiol. 1990;132:895-901.
23. Barrett-Connor E. Lower endogenous androgen levels and dyslipidemia in men with non-insulin dependent diabetes mellitus. Ann Intern Med. 1992;117:807-11.
24. Zietz B, Cuk A, Hugi S, et al. Association of increased C-peptide serum levels and testosterone in type 2 diabetes. Eur J Intern Med. 2000;11:322-8.
25. Birkeland KI, Hanssen KF, Torjesen PA, Vaaler S. Level of sex hormone-binding globulin is positively correlated with insulin sensitivity in men with type 2 diabetes. J Clin Endocrinol Metab. 1993;76:275-8.
26. Haffner SM, Karhapaa P, Mykkanen L, et al. Insulin resistance, body fat distribution, and sex hormones in men. Diabetes. 1994;43:212-9.
27. Haffner SM. Sex hormones, obesity, fat distribution, type 2 diabetes and insulin resistance: epidemiological and clinical correlation. Int J Obes Relat Metab Disord. 2000;24:(suppl 2):S56-8.
28. Evans DJ, Hoffman RG, Kalkhoff RK, Kissebah AH. Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women. J Clin Endocrinol Metab. 1993;57:304-10.
29. Plymate SR, Matij LA, Jones RE, Friedl KE. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep 72) cell line by insulin and prolactin. J Clin Endocrinol Metab. 1988;67:460-4.
30. Strain G, Zumoff B, Rosner W, Pi-Sunyer X. The relationship between serum levels of insulin and sex hormone-binding globulin in men: the effect of weight loss. J Clin Endocrinol Metab. 1994;79:1173-6.
31. Isidori AM, Caprio M, Strollo F, et al. Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels. J Clin Endocrinol Metab. 1999;84:3673-80.
32. Soderberg S, Olsson T, Eliasson M, et al. A strong association between biologically active testosterone and leptin in non-obese men and women is lost with increasing (central) adipocity. Int J Obes Relat Metab Disord. 2001;25:98-105.
33. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature. 1998;395:763-70.
34. Mantzoros CS. The role of leptin in human obesity and disease: a review of current evidence. Ann Intern Med. 1999; 130:671-80.
35. Cakir B, Yonem A, Guler S, et al. Relation of leptin and tumor necrosis factor-α to body weight changes in patients with pulmonary tuberculosis. Horm Res. 1999;52:279-83.
36. Halle M, Berg A, Garwers U, Grathwohl D, Knisel W, Keul J. Concurrent reduction of serum leptin and lipids during weight loss in obese men with type II diabetes. Am J Physiol. 1999;277:E277-82.
37. Haffner SM, Hanefeld M, Fischer S, Fucker K, Leonhardt W. Glibenclamide, but not acarbose, increases leptin concentrations, parallel to changes in insulin in subjects with NIDDM. Diabetes Care. 1997;20:1430-4.
38. Guler S, Cakir B, Demirbas B, Gursoy G, Serter R, Aral Y. Leptin concentrations are related to glycaemic control, but do not change with short-term oral antidiabetic therapy in female patients with type 2 diabetes mellitus. Diabetes Obes Metab. 2000;2:313-6.
39. Chu NF, Spiegelman D, Rifai N, Hotamisligil GS, Rimm EB. Glycemic status and soluble tumor necrosis factor receptor levels in relation to plasma leptin concentrations among normal weight and overweight US men. Int J Obes Relat Metab Disord. 2000;24:1085-92.
40. Moriya M, Okumura T, Takahashi N, Yamagata K, Motomura W, Kohgo Y. An inverse correlation between serum leptin levels and hemoglobin A1c in patients with non-insulin dependent diabetes mellitus. Diabetes Res Clin Pract. 1999; 43:187-91.
41. Ozata M, Gungor D, Turan M, et al. Improved glycemic control increases fasting plasma acylation stimulating protein (ASP) and decreases leptin concentrations in type 2 diabetic subjects. J Clin Endocrinol Metab. 2001;86. (in press).